Speaker illustration

Doctor Gokhan Cicek

Ankara Sehir Hospital, Ankara (Türkiye)

CHA2DS2-VASc score predicts contrast induced nephropathy in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Revascularisation

Session: Coronary artery disease: diagnosis, pharmacotherapy and revascularisation

Thumbnail

Two-year prognosis of admission hemoglobin a1c following a primary percutaneous coronary intervention

Event: ESC Congress 2017

Topic: Infarction acute phase STEMI

Session: Latest on STEMI

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb